154 related articles for article (PubMed ID: 22674379)
1. p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions.
Tanji K; Zhang HX; Mori F; Kakita A; Takahashi H; Wakabayashi K
J Neurosci Res; 2012 Oct; 90(10):2034-42. PubMed ID: 22674379
[TBL] [Abstract][Full Text] [Related]
2. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal lobar degeneration with ubiquitinated tau-negative inclusions and additional alpha-synuclein pathology but also unusual cerebellar ubiquitinated p62-positive, TDP-43-negative inclusions.
King A; Al-Sarraj S; Shaw C
Neuropathology; 2009 Aug; 29(4):466-71. PubMed ID: 18715271
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry.
Pikkarainen M; Hartikainen P; Alafuzoff I
J Neuropathol Exp Neurol; 2008 Apr; 67(4):280-98. PubMed ID: 18379439
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitinated p62-positive, TDP-43-negative inclusions in cerebellum in frontotemporal lobar degeneration with TAR DNA binding protein 43.
Pikkarainen M; Hartikainen P; Alafuzoff I
Neuropathology; 2010 Apr; 30(2):197-9. PubMed ID: 19622109
[No Abstract] [Full Text] [Related]
8. Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia.
Kovacs GG; van der Zee J; Hort J; Kristoferitsch W; Leitha T; Höftberger R; Ströbel T; Van Broeckhoven C; Matej R
Neuropathology; 2016 Feb; 36(1):27-38. PubMed ID: 26234378
[TBL] [Abstract][Full Text] [Related]
9. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD.
Roeber S; Mackenzie IR; Kretzschmar HA; Neumann M
Acta Neuropathol; 2008 Aug; 116(2):147-57. PubMed ID: 18536926
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
Mackenzie IR; Neumann M
Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
[TBL] [Abstract][Full Text] [Related]
11. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.
Mori K; Lammich S; Mackenzie IR; Forné I; Zilow S; Kretzschmar H; Edbauer D; Janssens J; Kleinberger G; Cruts M; Herms J; Neumann M; Van Broeckhoven C; Arzberger T; Haass C
Acta Neuropathol; 2013 Mar; 125(3):413-23. PubMed ID: 23381195
[TBL] [Abstract][Full Text] [Related]
12. Use of p62/SQSTM1 antibodies for neuropathological diagnosis.
Kuusisto E; Kauppinen T; Alafuzoff I
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):169-80. PubMed ID: 17961133
[TBL] [Abstract][Full Text] [Related]
13. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1.
Brady OA; Meng P; Zheng Y; Mao Y; Hu F
J Neurochem; 2011 Jan; 116(2):248-59. PubMed ID: 21062285
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions.
Josephs KA; Lin WL; Ahmed Z; Stroh DA; Graff-Radford NR; Dickson DW
Acta Neuropathol; 2008 Aug; 116(2):159-67. PubMed ID: 18553091
[TBL] [Abstract][Full Text] [Related]
15. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration.
Neumann M; Igaz LM; Kwong LK; Nakashima-Yasuda H; Kolb SJ; Dreyfuss G; Kretzschmar HA; Trojanowski JQ; Lee VM
Acta Neuropathol; 2007 May; 113(5):543-8. PubMed ID: 17415574
[TBL] [Abstract][Full Text] [Related]
16. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
17. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
[TBL] [Abstract][Full Text] [Related]
18. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis.
Droppelmann CA; Keller BA; Campos-Melo D; Volkening K; Strong MJ
Neurobiol Aging; 2013 Jan; 34(1):248-62. PubMed ID: 22835604
[TBL] [Abstract][Full Text] [Related]
19. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
[TBL] [Abstract][Full Text] [Related]
20. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.
Walker AK; Tripathy K; Restrepo CR; Ge G; Xu Y; Kwong LK; Trojanowski JQ; Lee VM
Hum Mol Genet; 2015 Dec; 24(25):7241-54. PubMed ID: 26476406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
